BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike?

Mark C. Markowski; Emmanuel S. Antonarakis

doi:10.1200/JCO.20.02246

BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike?

Mark C. Markowski
, Emmanuel S. Antonarakis

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	3735-3739
Number of pages	5
Journal	Journal of Clinical Oncology
Volume	38
Issue number	32
DOIs	https://doi.org/10.1200/JCO.20.02246
State	Published - Nov 10 2020
Externally published	Yes

Bibliographical note

Funding Information:
Supported by National Institutes of Health Cancer Center Support Grant P30CA006973 (E.S.A.) and a Prostate Cancer Foundation Young Investigator Award (M.C.M). The authors thank Alexander Baras for assistance with analysis and interpretation of the cBioPortal database and Su Jin Lim and Hao Wang for assistance with pooled biostatistical analyses

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1200/JCO.20.02246

Find It

Find It at U of M Libraries

Cite this

@article{330843345ad448e4b3c4ab6d585a8e83,

title = "BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike?",

author = "Markowski, \{Mark C.\} and Antonarakis, \{Emmanuel S.\}",

note = "Funding Information: Supported by National Institutes of Health Cancer Center Support Grant P30CA006973 (E.S.A.) and a Prostate Cancer Foundation Young Investigator Award (M.C.M). The authors thank Alexander Baras for assistance with analysis and interpretation of the cBioPortal database and Su Jin Lim and Hao Wang for assistance with pooled biostatistical analyses",

year = "2020",

month = nov,

day = "10",

doi = "10.1200/JCO.20.02246",

language = "English (US)",

volume = "38",

pages = "3735--3739",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "32",

}

TY - JOUR

T1 - BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer

T2 - More Different Than Alike?

AU - Markowski, Mark C.

AU - Antonarakis, Emmanuel S.

N1 - Funding Information: Supported by National Institutes of Health Cancer Center Support Grant P30CA006973 (E.S.A.) and a Prostate Cancer Foundation Young Investigator Award (M.C.M). The authors thank Alexander Baras for assistance with analysis and interpretation of the cBioPortal database and Su Jin Lim and Hao Wang for assistance with pooled biostatistical analyses

PY - 2020/11/10

Y1 - 2020/11/10

UR - https://www.scopus.com/pages/publications/85095862303

UR - https://www.scopus.com/pages/publications/85095862303#tab=citedBy

U2 - 10.1200/JCO.20.02246

DO - 10.1200/JCO.20.02246

M3 - Review article

C2 - 32870734

AN - SCOPUS:85095862303

SN - 0732-183X

VL - 38

SP - 3735

EP - 3739

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 32

ER -

BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike?

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this